The first four months of Serenite’s Entourage program are beginning to reveal which experiences customers want to revisit, what they found meaningful, and why stronger isn’t necessarily better.
We can tell you what’s in a Serenite capsule. We can tell you its measured mushroom potency, its lineage, and how carefully it was produced.
But there’s something we can’t learn from a potency test.
What happens when someone actually experiences it?
That’s the question behind Entourage, our customer observation program.
Since June, verified Serenite customers have been recording their experiences across our catalog. They tell us about their emotional state, mental and physical energy, the qualities they noticed, and whether the experience was one they’d welcome again.
On October 14, we completed our first four-month review.
The result: 134 qualifying observations from 73 customers, covering 25 products.
It’s still early. But there’s enough information to begin separating assumptions about our mushrooms from what our customers are actually reporting.
And a few of the findings surprised us.
The first important number: 78%
104 of 134 observations received a high revisit rating.
That’s 78%.
Entourage asks customers to rate their affinity for an experience on a five-point scale. A four or five means they felt strongly enough about the experience to indicate they would consider revisiting it.
The full distribution tells a useful story:
| Revisit rating | Observations | Share |
|---|---|---|
| High (4–5) | 104 | 78% |
| Middle (3) | 16 | 12% |
| Low (1–2) | 14 | 10% |
The average affinity score across all 134 observations was 4.07 out of 5.
That’s encouraging, but it deserves context. These aren’t randomly selected consumers. They are verified customers who chose to participate and submit observations. That makes Entourage especially valuable for learning about our engaged customers, but the results shouldn’t be mistaken for a prediction of how every buyer will respond.
We also want to understand the experiences that weren’t worth repeating. Those observations can be every bit as useful as the enthusiastic ones.
What are people actually finding?
When someone tells us they would revisit an experience, the next question is why.
We look at the qualities they reported finding in that experience, rather than simply counting every expectation or intention.
Among the 104 high-affinity observations, these eight qualities appeared most frequently:
| Reported experience | Observations |
|---|---|
| Mood lift | 73 |
| Energy / feeling less tired | 50 |
| Emotional openness | 49 |
| Social ease | 45 |
| General wellness | 37 |
| Creative focus | 37 |
| Fresh perspective / exploration | 36 |
| Calm | 30 |
These categories overlap. One observation can include several qualities.
Mood lift is the most frequently reported quality, appearing in approximately 70% of high-affinity observations.
But look beyond mood.
Energy, emotional openness, social ease, creativity, and perspective also appear repeatedly.
This is one reason we’re interested in more than simply asking whether a mushroom was strong or mild. Strength describes only one dimension of an experience. What someone values about it may be quite different.
For one customer, a satisfying experience might mean feeling more socially engaged. For another, it might mean having room for reflection, or finding a creative thread worth following.
Those distinctions are important when choosing among mushrooms with different reported characteristics.
Five products are beginning to distinguish themselves
The Serenite catalog contains mushrooms with different lineages, potency measurements, and histories.
Entourage adds something new: observations of what customers actually found worthwhile about them.
Five products now have at least nine observations and high revisit ratings in at least 73% of those reports.
| Product | Observations | High revisit | Frequently reported qualities |
|---|---|---|---|
| Enigma | 14 | 86% | Mood, perspective, creativity, social ease |
| Albino Tidal Wave – Maelstrom | 12 | 92% | Mood, emotional openness, energy, perspective |
| Non Human Intelligence | 11 | 73% | Mood, emotional openness, perspective, energy |
| Pearl White | 11 | 91% | Mood, emotional openness, perspective |
| My Blue Heaven XL | 9 | 89% | Mood, emotional openness, social ease, wellness |
These aren’t rankings of the best mushrooms. The sample sizes are still modest, and some customers have submitted more than one observation for a product.
But they are useful early signals.
Maelstrom, for example, has a particularly high concentration of favorable revisit ratings. Pearl White shows a similarly encouraging pattern. Non Human Intelligence has a lower revisit percentage but a recognizable group of reported qualities.
The purpose isn’t to declare a winner. It’s to understand the differences, and eventually make choosing a mushroom a more informed decision.
A closer look at Enigma
Enigma is a particularly interesting example because we have 14 observations from 14 different customers.
Twelve of those 14 customers gave their experience a high revisit rating.
Within those high-affinity reports, customers identified:
- Mood lift — 9 observations
- Fresh perspective or exploration — 9
- Creative focus — 7
- Social ease — 6
That combination is interesting.
The data suggest that customers who particularly valued their Enigma experiences frequently found something beyond simple intensity. They reported changes in outlook, opportunities for creative thinking, and a greater sense of ease engaging with others.
This doesn’t mean Enigma will produce those outcomes for everyone. Nor does it mean that these are exclusive properties of Enigma.
It means that, among these 14 customers, a recognizable pattern is beginning to emerge.
And that’s more informative than relying on a reputation alone.
Does stronger mean better? Not necessarily.
Here’s one of the most useful findings from our first review.
We compared estimated psilocybin content per capsule with the revisit ratings customers assigned to their experiences.
Among high-affinity observations with usable potency information, we divided capsules into three potency groups.
| Estimated potency per capsule | Observations | Average revisit rating |
|---|---|---|
| Lower third | 38 | 4.58 / 5 |
| Middle third | 38 | 4.42 / 5 |
| Upper third | 25 | 4.72 / 5 |
The approximate dividing points were 2.88 mg and 4.18 mg per capsule.
Notice something?
The middle group had a slightly lower average revisit rating than the lower group. The upper group scored highest, but not by enough, or in a sufficiently consistent progression, to establish a simple relationship between potency and satisfaction.
Among customers who already liked their experiences, stronger capsules did not produce a clean, steadily increasing pattern of satisfaction.
There are important limitations. These figures describe high-affinity observations only, not everyone who participated. Estimated potency per capsule is not the same as total consumed dose, and the groups are not matched for product, person, or circumstances.
We shouldn’t conclude that potency doesn’t matter.
It clearly can matter to the character and intensity of an experience.
What these observations do suggest is that potency alone is a poor substitute for understanding what someone actually wants from the experience.
A more powerful capsule isn’t automatically a more desirable one.
What about experiences customers didn’t love?
One of the more important commitments we made when creating Entourage was that we would pay attention to disappointment, not simply collect praise.
Consider Golden Teacher Lite.
Among seven observations, three received high revisit ratings, two fell in the middle, and two received low ratings.
That’s a much less decisive pattern than we’re seeing in products such as Enigma or Maelstrom.
Golden Teacher Lite also has a substantially lower estimated potency, approximately 0.72 mg per capsule in this dataset.
Does that mean it’s a poor product?
No. Seven observations aren’t enough to make that judgment. Nor can we determine from these data whether the differing ratings reflect potency, expectations, personal preferences, or other circumstances.
What it tells us is that we need to investigate whether the product is meeting the expectations of the customers choosing it.
That is exactly the kind of question Entourage was built to answer.
At present, no product has accumulated a sufficiently substantial concentration of unfavorable observations to justify a broad negative conclusion.
What our measurements can—and cannot—tell us
We believe customers deserve to understand what these numbers mean.
Entourage is not a clinical trial. It is a structured record of experiences voluntarily reported by verified purchasers.
We use several distinct measurements.
Revisit affinity tells us whether someone valued an experience enough to consider repeating it.
Reported qualities tell us what people noticed or found meaningful. For the experience patterns in this report, we count these qualities only when the observation received a high affinity rating.
Experience scales measure emotional, cognitive, physical, and sensory dimensions on a five-point scale. Across the full set of observations, the averages were 3.54 emotional, 3.47 cognitive, 3.19 body, and 3.35 sensory.
Potency estimates use the product’s available potency data and capsule fill information. We had estimated milligrams per capsule for 129 of the 134 observations. Where capsule count was also available, we could estimate total exposure. These are estimates, not individual clinical assays of consumed capsules.
We also excluded 25 submitted records from this consensus analysis under our observation inclusion rules.
All of this helps us examine patterns, but it doesn’t establish medical efficacy, prove cause and effect, or tell us precisely how any individual will respond.
There are other limitations. We don’t yet have enough observations for confident conclusions about many individual products. Enthusiastic customers may be more likely to participate. And personal circumstances, expectations, experience, and amounts consumed can all affect what someone reports.
We intend to be equally candid about those limitations and the discoveries.
Where Entourage goes from here
Four months and 134 observations are a beginning, not a conclusion.
As participation grows, we expect to develop a clearer understanding of which experiences are most consistently valued, which products serve different preferences, and where our descriptions need to change to reflect what customers actually find.
We’re especially interested in the differences between products that might look similar on a potency chart but inspire different experiences in practice.
For years, mushroom descriptions have relied heavily on cultivar reputations, anecdotes, and generalized expectations.
We believe there’s a better way to learn.
Ask verified customers. Give them a consistent way to describe their experiences. Count the results. Keep looking for patterns. And be willing to change our minds when the evidence changes.
That’s what Entourage is here to do.
Your experience is part of the evidence
If you’ve submitted an Entourage observation, you’re part of these first 134 records. Thank you.
If you haven’t, we’d welcome your participation.
An especially valuable observation isn’t necessarily an enthusiastic one. It’s an accurate one.
Tell us what you experienced, whether you’d revisit it, and what stood out—pleasant, unremarkable, or otherwise.
The more carefully we listen, the more useful this growing body of knowledge becomes for everyone choosing their next Serenite experience.
